Saturday 7 November 2026
Export MDXG’s income statement to Excel — free account
MiMedx Group, Inc
MDXG Healthcare Biotechnology
MiMedx Group, Inc’s revenue for fiscal 2025 (year ended December 2025) was $418.6 million, up 20.0% from fiscal 2024.
- Revenue
- −45.2%
- EPS
- −154.1%
- Free cash flow
- −87.2%
- Total debt
- −6.80%
Quarter to September 2026, against a year earlier
3.31
0.03
+0.91%
Follow MDXG
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 5 | 5 |
+8 more TTM periods Free account |
| (8.53%) | 2.88% | 13.77% | 21.61% | ||
| (6.58%) | 2.18% | 10.60% | 16.02% | ||
ROIC |
(17.40%) | 5.62% | 24.56% | 36.84% | |
Return on Tangible Assets |
(12.89%) | 3.63% | 15.31% | 22.29% | |
Average Days of Receivables |
44.79 | 42.44 | 43.15 | 66.01 | |
Free Cash Flow per Share |
0.13 | 0.30 | 0.47 | 0.49 | |
Free Cash Flow |
19.02 | 44.43 | 69.31 | 72.97 | |
Capital Expenditures |
(1.72) | (1.72) | (1.27) | (1.03) | |
| Other line items | |||||
Cash ROIC |
5.73% | 12.04% | 16.49% | 16.56% | |
Accounts Receivable Turnover |
5.26 | 6.43 | 7.19 | 6.37 | |
Accounts Payable Turnover |
5.94 | 8.95 | 7.26 | 6.66 | |
Inventory Turnover |
2.84 | 3.28 | 2.94 | 2.97 | |
Average Days of Payables |
62.58 | 40.29 | 56.68 | 72.63 | |
Days of Inventory on Hand |
116.87 | 101.70 | 129.68 | 126.68 | |
Tax Rate |
(0.14) | (0.46) | (0.27) | (0.27) | |
Research and Development Expense of Revenue |
4.77% | 4.33% | 4.09% | 3.61% | |
Selling, General and Administrative Expense of Revenue |
80.46% | 71.82% | 66.63% | 63.59% | |
Share Based Compensation of Revenue |
1.61% | 1.86% | 2.68% | 3.92% | |
Operating CF/Net income |
(1.08) | 7.40 | 2.30 | 1.52 | |
Depreciation/Fixed assets |
1.66 | 2.37 | 2.80 | 3.16 | |
Capex/Depreciation |
(0.22) | (0.15) | (0.10) | (0.07) | |
Revenue per Share |
2.08 | 2.40 | 2.62 | 2.83 | |
Operating CF per Share |
0.14 | 0.31 | 0.48 | 0.50 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026